Literature DB >> 29934328

BMP7 Signaling in TGFBR2-Deficient Stromal Cells Provokes Epithelial Carcinogenesis.

Hans Petter Eikesdal1,2, Lisa M Becker1, Yingqi Teng2, Akane Kizu2, Julienne L Carstens1, Keizo Kanasaki2, Hikaru Sugimoto1,2, Valerie S LeBleu1,2, Raghu Kalluri3,2,4,5.   

Abstract

Deregulated transforming growth factor-β (TGFβ) signaling is a common feature of many epithelial cancers. Deletion of TGFβ receptor type 2 (TGFBR2) in fibroblast specific protein-1 (FSP1)-positive stromal cells induces squamous cell carcinoma in the murine forestomach, implicating fibroblast-derived hepatocyte growth factor (HGF) as the major driver of the epithelium carcinogenesis. Prior to cancer development, hyperproliferative FSP1+ fibroblasts lacking TGFBR2 accumulate in the forestomach, disrupting the regulatory signaling cross-talk with the forestomach epithelium. Here, concurrent loss in TGFBR2 and SMAD4 completely abrogates the development of forestomach cancer. Bone morphogenic protein-7 (BMP7) was highly upregulated in forestomach cancer tissue, activating Smad1/5/8 signaling, cell proliferation, and HGF production in TGFBR2-deficient FSP1+ fibroblasts. This stimulation by BMP7 was lost in the combined TGFBR2 and SMAD4 double knockout fibroblasts, which included a profound decrease in HGF expression. Thus, Smad4-mediated signaling is required to initiate epithelial carcinogenesis subsequent to TGFBR2 deletion in FSP1+ fibroblasts.Implications: These findings reveal a complex cross-talk between epithelial cells and the stroma, wherein Smad4 is required to elicit squamous cell carcinomas in the forestomach of mice with TGFBR2-deficient stromal cells. Mol Cancer Res; 16(10); 1568-78. ©2018 AACR. ©2018 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29934328      PMCID: PMC6170697          DOI: 10.1158/1541-7786.MCR-18-0120

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  50 in total

1.  Conditional inactivation of the TGF-beta type II receptor using Cre:Lox.

Authors:  Anna Chytil; Mark A Magnuson; Christopher V E Wright; Harold L Moses
Journal:  Genesis       Date:  2002-02       Impact factor: 2.487

2.  Disruption of bone morphogenetic protein receptor 2 (BMPR2) in mammary tumors promotes metastases through cell autonomous and paracrine mediators.

Authors:  Philip Owens; Michael W Pickup; Sergey V Novitskiy; Anna Chytil; Agnieszka E Gorska; Mary E Aakre; James West; Harold L Moses
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-16       Impact factor: 11.205

3.  Distinct epigenetic changes in the stromal cells of breast cancers.

Authors:  Min Hu; Jun Yao; Li Cai; Kurt E Bachman; Frédéric van den Brûle; Victor Velculescu; Kornelia Polyak
Journal:  Nat Genet       Date:  2005-07-10       Impact factor: 38.330

Review 4.  The biology and function of fibroblasts in cancer.

Authors:  Raghu Kalluri
Journal:  Nat Rev Cancer       Date:  2016-08-23       Impact factor: 60.716

5.  Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas.

Authors:  Keisuke Kurose; Kristie Gilley; Satoshi Matsumoto; Peter H Watson; Xiao-Ping Zhou; Charis Eng
Journal:  Nat Genet       Date:  2002-10-15       Impact factor: 38.330

6.  Identification of amino acids essential for the antiangiogenic activity of tumstatin and its use in combination antitumor activity.

Authors:  Hans Petter Eikesdal; Hikaru Sugimoto; Gabriel Birrane; Yohei Maeshima; Vesselina G Cooke; Mark Kieran; Raghu Kalluri
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-25       Impact factor: 11.205

7.  p38MAPK acts in the BMP7-dependent stimulatory pathway during epithelial cell morphogenesis and is regulated by Smad1.

Authors:  Ming Chang Hu; David Wasserman; Sunny Hartwig; Norman D Rosenblum
Journal:  J Biol Chem       Date:  2004-01-12       Impact factor: 5.157

8.  Stromal inactivation of BMPRII leads to colorectal epithelial overgrowth and polyp formation.

Authors:  H Beppu; O N Mwizerwa; Y Beppu; M P Dattwyler; G Y Lauwers; K D Bloch; A M Goldstein
Journal:  Oncogene       Date:  2007-08-13       Impact factor: 9.867

9.  Origin and function of myofibroblasts in kidney fibrosis.

Authors:  Valerie S LeBleu; Gangadhar Taduri; Joyce O'Connell; Yingqi Teng; Vesselina G Cooke; Craig Woda; Hikaru Sugimoto; Raghu Kalluri
Journal:  Nat Med       Date:  2013-06-30       Impact factor: 53.440

10.  Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer.

Authors:  Julienne L Carstens; Pedro Correa de Sampaio; Dalu Yang; Souptik Barua; Huamin Wang; Arvind Rao; James P Allison; Valerie S LeBleu; Raghu Kalluri
Journal:  Nat Commun       Date:  2017-04-27       Impact factor: 14.919

View more
  4 in total

1.  Genetic architectures of proximal and distal colorectal cancer are partly distinct.

Authors:  Jeroen R Huyghe; Tabitha A Harrison; Stephanie A Bien; Heather Hampel; Jane C Figueiredo; Stephanie L Schmit; David V Conti; Sai Chen; Conghui Qu; Yi Lin; Richard Barfield; John A Baron; Amanda J Cross; Brenda Diergaarde; David Duggan; Sophia Harlid; Liher Imaz; Hyun Min Kang; David M Levine; Vittorio Perduca; Aurora Perez-Cornago; Lori C Sakoda; Fredrick R Schumacher; Martha L Slattery; Amanda E Toland; Fränzel J B van Duijnhoven; Bethany Van Guelpen; Antonio Agudo; Demetrius Albanes; M Henar Alonso; Kristin Anderson; Coral Arnau-Collell; Volker Arndt; Barbara L Banbury; Michael C Bassik; Sonja I Berndt; Stéphane Bézieau; D Timothy Bishop; Juergen Boehm; Heiner Boeing; Marie-Christine Boutron-Ruault; Hermann Brenner; Stefanie Brezina; Stephan Buch; Daniel D Buchanan; Andrea Burnett-Hartman; Bette J Caan; Peter T Campbell; Prudence R Carr; Antoni Castells; Sergi Castellví-Bel; Andrew T Chan; Jenny Chang-Claude; Stephen J Chanock; Keith R Curtis; Albert de la Chapelle; Douglas F Easton; Dallas R English; Edith J M Feskens; Manish Gala; Steven J Gallinger; W James Gauderman; Graham G Giles; Phyllis J Goodman; William M Grady; John S Grove; Andrea Gsur; Marc J Gunter; Robert W Haile; Jochen Hampe; Michael Hoffmeister; John L Hopper; Wan-Ling Hsu; Wen-Yi Huang; Thomas J Hudson; Mazda Jenab; Mark A Jenkins; Amit D Joshi; Temitope O Keku; Charles Kooperberg; Tilman Kühn; Sébastien Küry; Loic Le Marchand; Flavio Lejbkowicz; Christopher I Li; Li Li; Wolfgang Lieb; Annika Lindblom; Noralane M Lindor; Satu Männistö; Sanford D Markowitz; Roger L Milne; Lorena Moreno; Neil Murphy; Rami Nassir; Kenneth Offit; Shuji Ogino; Salvatore Panico; Patrick S Parfrey; Rachel Pearlman; Paul D P Pharoah; Amanda I Phipps; Elizabeth A Platz; John D Potter; Ross L Prentice; Lihong Qi; Leon Raskin; Gad Rennert; Hedy S Rennert; Elio Riboli; Clemens Schafmayer; Robert E Schoen; Daniela Seminara; Mingyang Song; Yu-Ru Su; Catherine M Tangen; Stephen N Thibodeau; Duncan C Thomas; Antonia Trichopoulou; Cornelia M Ulrich; Kala Visvanathan; Pavel Vodicka; Ludmila Vodickova; Veronika Vymetalkova; Korbinian Weigl; Stephanie J Weinstein; Emily White; Alicja Wolk; Michael O Woods; Anna H Wu; Goncalo R Abecasis; Deborah A Nickerson; Peter C Scacheri; Anshul Kundaje; Graham Casey; Stephen B Gruber; Li Hsu; Victor Moreno; Richard B Hayes; Polly A Newcomb; Ulrike Peters
Journal:  Gut       Date:  2021-02-25       Impact factor: 31.793

2.  Imbalance of TGF-β1/BMP-7 pathways induced by M2-polarized macrophages promotes hepatocellular carcinoma aggressiveness.

Authors:  Junya Ning; Yingnan Ye; Dechao Bu; Gang Zhao; Tianqiang Song; Pengpeng Liu; Wenwen Yu; Hailong Wang; Hui Li; Xiubao Ren; Guoguang Ying; Yi Zhao; Jinpu Yu
Journal:  Mol Ther       Date:  2021-02-15       Impact factor: 12.910

3.  Organotypic Epithelial Raft Cultures as a Three-Dimensional In Vitro Model of Merkel Cell Carcinoma.

Authors:  Arturo Temblador; Dimitrios Topalis; Joost van den Oord; Graciela Andrei; Robert Snoeck
Journal:  Cancers (Basel)       Date:  2022-02-21       Impact factor: 6.639

4.  SMAD1 as a biomarker and potential therapeutic target in drug-resistant multiple myeloma.

Authors:  Jian Wu; Min Zhang; Omar Faruq; Eldad Zacksenhaus; Wenming Chen; Aijun Liu; Hong Chang
Journal:  Biomark Res       Date:  2021-06-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.